Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 48Leukemia 46Anemia, Refractory, with Excess of Blasts 43Leukemia, Myeloid, Acute 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Chronic 29Leukemia, Myeloid, Chronic-Phase 26Lymphoma 25Myeloproliferative Disorders 22Multiple Myeloma 22Lymphoma, Non-Hodgkin 21Leukemia, Myeloid, Accelerated Phase 21Congenital Abnormalities 21Leukemia, Lymphocytic, Chronic, B-Cell 20Blast Crisis 20Anemia, Refractory 20Burkitt Lymphoma 17Myelodysplastic-Myeloproliferative Diseases 16Hodgkin Disease 16Primary Myelofibrosis 15Lymphoma, Follicular 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Dendritic Cell Sarcoma, Interdigitating 14Anemia, Aplastic 14Neoplasms, Plasma Cell 13Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Lymphoma, Large B-Cell, Diffuse 13Lymphoma, B-Cell, Marginal Zone 13Recurrence 11

Interventions

fludarabine phosphate 4fludarabine 4Cyclophosphamide 4Thiotepa 3Melphalan 3Whole-Body Irradiation 2Tacrolimus 2Surveys and Questionnaires 2Fentanyl 2Busulfan 2Alemtuzumab 2AP 1903 reagent 2voxelotor 1thymoglobulin 1maltodextrin 1Rituximab 1Registries 1Range of Motion, Articular 1Protease Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Medical Marijuana 1Interviews as Topic 1Imagery, Psychotherapy 1Holistic Health 1Glutamine 1Erythrocyte Count 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia, Sickle Cell × Busulfan × Classical hematology × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡